Analystreport

Evolent Health, Inc. (NYSE: EVH) had its price target raised by analysts at Canaccord Genuity from $24.00 to $27.00. They now have a "buy" rating on the stock.

Evolent Health, Inc Class A  (EVH) 
Last evolent health, inc class a earnings: 2/25 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ir.evolenthealth.com